Consort Medical

Bringing Aesica together with Bespak within the Consort Medical group builds on Bespak’s rich drug delivery device heritage over the last 50 years and Aesica’s decade-long expansion into a leading European pharmaceutical CDMO. Today, Consort Medical is a leading, global, single source drug and delivery device CDMO. Optimising world-class drug delivery device development and manufacture, together with API and finished dose drug formulation and manufacture, within the same group streamlines and accelerates our pharmaceutical customers’ drug route to market. Consort Medical remains at the leading edge of innovation and is committed to investing in patient- and customer-driven innovation with the potential to create new treatments, new markets and new opportunities.

Hemel Hempstead, GB
Size (employees)
1,984 (est)
Consort Medical is headquartered in Hemel Hempstead, GB

Consort Medical Office Locations

Consort Medical has offices in Hemel Hempstead, Cambridge, Northumberland, North Lynn Industrial Estate and in 7 other locations
Hemel Hempstead, GB (HQ)
Breakspear Way
Pianezza, IT
15 Via Praglia
Zwickau, DE
6 Galileistraße
Monheim am Rhein, DE
10 Alfred-Nobel-Straße
Queenborough, GB
North Rd
Wolverton, GB
Blackhill Dr
Show all (11)

Consort Medical Data and Metrics

Consort Medical Financial Metrics

Consort Medical's revenue was reported to be £276.9 m in FY, 2016 which is a 50% increase from the previous period.

Revenue (FY, 2016)

276.9 m

Revenue growth (FY, 2015 - FY, 2016), %


Gross profit (FY, 2016)

16 m

Gross profit margin (FY, 2016), %


Net income (FY, 2016)

16 m

Market capitalization (25-Jul-2017)

522.3 m

Closing share price (25-Jul-2017)


Cash (30-Apr-2016)

16.3 m
Consort Medical's current market capitalization is £522.3 m.
GBPFY, 2014FY, 2015FY, 2016


100 m184.8 m276.9 m

Revenue growth, %


Cost of goods sold

176.7 m261 m

Gross profit

8.2 m16 m

Gross profit Margin, %


Pre tax profit

16.1 m5.5 m11.2 m

Net Income

13.6 m6.3 m16 m
GBPFY, 2014FY, 2015FY, 2016


25.8 m45.2 m16.3 m

Accounts Receivable

13.6 m47 m45.2 m

Current Assets

64 m139.1 m110.9 m


58.9 m135.3 m144.9 m


20.8 m194.4 m189.9 m

Total Assets

143.7 m468.8 m445.8 m

Accounts Payable

6.1 m24.1 m27.2 m

Current Liabilities

17.9 m223 m178.8 m

Total Liabilities

25.2 m268.3 m236.6 m

Retained Earnings

7.2 m(2.1 m)6 m

Total Equity

118.5 m200.5 m209.2 m

Financial Leverage

1.2 x2.3 x2.1 x
GBPFY, 2014FY, 2015FY, 2016

Cash From Operating Activities

13.8 m12.1 m37.4 m

Cash From Financing Activities

(8.4 m)231.6 m(45.9 m)

Income Taxes Paid

(2.5 m)750 k4.7 m
GBPY, 2016


140.3 k

Financial Leverage

2.1 x

Consort Medical Market Value History

Consort Medical Job Categories

Traffic Overview of Consort Medical

Consort Medical Online and Social Media Presence

Consort Medical News and Updates

City Moves for 28 November 2016 | Who’s switching jobs

Ashurst International law firm Ashurst has appointed Jan Gooze-Zijl as chief financial and operations officer and he will join the firm in February 2017. Jan joins from multichannel broadcaster UKTV where he is chief financial and operations officer, responsible for all financial decision-making …

Attacking Hearing Loss, Brain Injury, And More: 12 Early-Stage Medical Device Startups To Watch

Since 2012, deals to early-stage medical device companies have hovered around 30% of total deal volume to the category. VCs and corporate investors alike are continuing to fund medical device startups in 2016 and the category is on track to see another year of increased … Continued

Corporates Ramp Up Involvement In Medical Device Industry

Corporations and their investment arms — including Johnson & Johnson, Kaiser Permanente, and Medtronic — have been participating in major deals to medical device startups. These include large late-stage deals into CVRx, Acutus Medical, and Transmedics. Additionally, deals with corporate backing …
Show more

Consort Medical Company Life and Culture

You may also be interested in